Although the difference did not reach statistical significance in that study, resistant isolates were observed nearly twice as frequently in MTX-treated patients compared to antifolate-naive individuals.
← all excerpts
Systemic Antifolate Chemotherapy Does Not Select for Fluconazole-Resistant <i>Candida</i>: A Multicenter Clinical Study.
1
—
—